Sociodemographic Profile, Disease Severity, and Treatment Patterns in Patients with Cutaneous Lupus Erythematosus Attending a Tertiary Care Hospital


PDF PDF

Keywords

cutaneous lupus erythematosus
sociodemographic factors
CLASI
disease severity
hydroxychloroquine
treatment pattern
Bangladesh

How to Cite

1.
Sociodemographic Profile, Disease Severity, and Treatment Patterns in Patients with Cutaneous Lupus Erythematosus Attending a Tertiary Care Hospital. Planet (Barisal) [Internet]. 2026 Nov. 8 [cited 2026 Nov. 17];10(03):1240-5. Available from: https://bdjournals.org/planet/article/view/1643

Abstract

Background: Cutaneous lupus erythematosus (CLE) is a chronic autoimmune skin disease that occurs alone or with systemic lupus erythematosus (SLE). Data on its sociodemographic profile, disease severity and treatment patterns are limited in Bangladesh. Objective: To describe the sociodemographic profile of patients with CLE attending a tertiary hospital, assess disease severity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and describe their treatment patterns. Methods & Materials: This descriptive cross-sectional hospital-based study was conducted at Chittagong Medical College Hospital, Chattogram from January to December 2023. Consecutive adults with CLE, with or without SLE, were enrolled after informed consent. Sociodemographic and clinical data were collected by interview and record review and disease activity was measured with the CLASI activity score. Current and previous drug treatment was recorded. Data were summarized descriptively; no comparative hypothesis testing was performed. Results: Of 100 patients assessed, 96 were analysed (mean age 32.5 ± 11.6 years; 91.7% female; female to male ratio 11:1). Most patients were from rural areas (69.8%), married (82.3%) and housewives (68.8%); 43.8% belonged to the upper lower socioeconomic class. Generalized cutaneous disease was present in 80.2% and systemic manifestations in 86.5%. The mean CLASI activity score was 13.8 ± 10.3; disease activity was mild in 44.8%, moderate in 33.3% and severe in 21.9%. Mean body mass index was 22.7 kg/m², with 17.7% obese and 25.0% underweight. Before enrolment, 76.0% had received combined systemic and topical treatment. At assessment, hydroxychloroquine was used by 78.1% and prednisolone by 44.8%, usually in combination, while 8.3% were on no systemic immunosuppressant. Conclusion: Patients with CLE at this tertiary centre were predominantly young women of rural, lower socioeconomic background with generalized skin disease and frequent systemic involvement. Disease activity was mild to moderate in most patients and hydroxychloroquine with or without corticosteroids was the dominant treatment approach. These descriptive data can guide service planning and patient counselling in similar settings.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 The Planet